Abstract: This invention relates to a composition of the plant Withania Somnifera, and, more particularly to a high purity extract composition with advantageous levels of withanolide glycosides and oligosaccharides, a minimum of polysaccharides, and substantially low levels of free withaferin A and equivalents (withanolide aglycones), which composition provides enhanced cognition-enhancing effects for the user, and an extraction process for obtaining such composition, as well as pharmaceutical, nutritional and personal care use products thereof.
Type:
Application
Filed:
February 26, 2004
Publication date:
August 26, 2004
Applicants:
NATREON INC., INDIAN HERBS RESEARCH & SUPPLY COMPANY LTD.
Abstract: A light colored standardized extract of Emblica officinalis consisting essentially of over 40% by weight of Emblicanin A. Emblicanin B, Pedunculagin and Punigluconin, and not more than about 1% by weight of flavonoids, and methods of producing same. Also disclosed are cosmetic or pharmaceutical compositions comprising the standardized extract and methods of using same to lighten or whiten skin.
Type:
Application
Filed:
June 25, 2003
Publication date:
May 6, 2004
Applicants:
EM Industries, Hawthorne, New York, Natreon Inc., New Brunswick, New Jersey
Abstract: This invention relates to a composition of the plant Withania Somnifera, and, more particularly to a high purity extract composition with advantageous levels of withanolide glycosides and oligosaccharides, a minimum of polysaccharides, and substantially low levels of free withaferin A and equivalents (withanolide aglycones), which composition provides enhanced cognition-enhancing effects for the user, and an extraction process for obtaining such composition, as well as pharmaceutical, nutritional and personal care use products thereof.
Type:
Grant
Filed:
December 3, 2002
Date of Patent:
March 30, 2004
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company Ltd.
Abstract: A light colored standardized extract of Emblica officinalis consisting essentially of over 40% by weight of Emblicanin A. Emblicanin B, Pedunculagin and Punigluconin, and not more than about 1% by weight of flavonoids, and methods of producing same. Also disclosed are cosmetic or pharmaceutical compositions comprising the standardized extract and methods of using same to lighten or whiten skin.
Abstract: A herbo-mineral composition includes a mineral-complexing agent which is purified Shilajit containing dimeric and/or oligomeric dibenzo-&agr;-pyrones (DBPs), and, optionally, in synergistic combination with an extract of Emblica officinalis containing gallo/ellagi-tannoids (GET), and, one or more added minerals, such as iron, copper or chromium. The composition in the example where the added mineral is iron is particularly effective in treating iron-deficiency anemia by rapidly absorbing ferrous iron into the blood stream without side effects.
Type:
Application
Filed:
April 23, 2002
Publication date:
October 23, 2003
Applicants:
NATREON INC., INDIAN HERBS RESEARCH, SUPPLY COMPANY LTD.
Abstract: A light colored standardized extract of Emblica officinalis consisting essentially of over 40% by weight of Emblicanin A. Emblicanin B, Pedunculagin and Punigluconin, and not more than about 1% by weight of flavonoids, and methods of producing same. Also disclosed are cosmetic or pharmaceutical compositions comprising the standardized extract and methods of using same to lighten or whiten skin.
Abstract: A stable, water-soluble delivery system of a purified Shilajit composition obtained by extraction of native Shilajit, containing at least 40% by weight of a carrier which is purified fulvic acid, characterized by having a sponge-like structure punctured by voids of about 200-1000 Å in diameter, and a {overscore (M)}n molecular weight of about 700-2500; and an effective amount of an active pharmaceutical, nutritional or cosmetic ingredient added to said carrier and filling voids therein.
Type:
Grant
Filed:
September 21, 2001
Date of Patent:
May 6, 2003
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company Ltd.
Abstract: A purified shilajit composition is provided herein from native shilajit. The composition has an abundance of bioactive components, particularly, at least 0.3%, preferably 0.4-1%, by weight, oxygenated dibenzo-&agr;-pyrones and at least 60%, preferably 65-70%, by weight of fulvic acids of low-to-medium molecular weight ({overscore (M)}n of 700-2000) with an E4/E6 ratio of 8-10 at 465-665 nm, and whose 2% aqueous solution has a pH of ≧7. Personal care, pharmaceutical and nutritional use formulations of the purified shilajit composition also are described.
Type:
Grant
Filed:
May 18, 2001
Date of Patent:
August 27, 2002
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company Ltd.
Abstract: A method of blocking free radical processes in an animal which result in mediated pathology without deleterious pro-oxidant side reactions which comprises administering an extract of the fruit of the Emblica officinalis plant to effect such advantageous result, preferably in a use formulation at an active use level of 0.005 to 5% by weight of the formulation.
Type:
Grant
Filed:
September 21, 2000
Date of Patent:
March 26, 2002
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company Ltd.
Abstract: A method of inhibiting blood platelet aggregation in humans which comprises administering an extract blend of the fruit of the Emblica officinalis plant to control said aggregation, suitably in a dose amount of about 50-500 mg/day.
Type:
Grant
Filed:
September 21, 2000
Date of Patent:
September 18, 2001
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company LTD
Abstract: A natural antioxidant blend in the form of an amphorous powder was obtained by extraction from Emblica officinalis fruit. In this process, the finely pulped fruit was treated with a dilute aqueous salt solution at hot water temperature to provide an extract-containing solution, which was filtered and dried to provide the desired antioxidant blend powder. A synergistically stabilized composition of ascorbic acid or its derivatives with the antioxidant composition of Emblica officinalis, is also described. Cosmetic, pharmaceutical and nutritional use formulations thereof also are described.
Abstract: A composition of St. John's Wort, in the form of a stable, free-flowing, powder, having effective antidepressant properties, characterized by having essentially no hypericin therein.
Type:
Grant
Filed:
August 31, 1999
Date of Patent:
May 1, 2001
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company Ltd.
Abstract: A high purity Withania somnifera extract composition in the form of a high purity, stable, free-flowing, light yellow-to-brown herbaceous powder, for producing an enhanced cognition effect for the user and to augment the learning facility in the geriatric population when taken in a dosage of 200-800 mg/day. This extract contains, by weight, (a) at least 3% of withanolide glycosides and sitoindosides, preferably 3-8%, (b) at least 3% of oligosaccharides, preferably 3-8%, preferably a molecular weight of <2000, and (c) less than 0.5% of free cytotoxic withaferin A (aglycone), wherein the ratio of (a):(c) is 75-95:25-5, and the ratio of (a):(b) is 40-60:60-40. An extraction process for obtaining such extract composition, and pharmaceutical and nutritional use products thereof, also are described.
Type:
Grant
Filed:
July 13, 1999
Date of Patent:
November 28, 2000
Assignees:
Natreon Inc., Indian Herbs Research & Supply Company Ltd.
Abstract: A natural antioxidant blend in the form of an amphorous powder was obtained by extraction from Emblica officinalis fruit. In this process, the finely pulped fruit was treated with a dilute aqueous salt solution at hot water temperature to provide an extract-containing solution, which was filtered and dried to provide the desired antioxidant blend powder. Cosmetic, pharmaceutical and nutritional use formulations thereof also are described.